Skip to content

The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants

Womb Recordings and Respiratory Control Maturation in Neonates

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05298748
Enrollment
34
Registered
2022-03-28
Start date
2022-09-16
Completion date
2026-11-30
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity, Bradycardia, Intermittent Hypoxemia

Keywords

apnea, intermittent hypoxemia, bradycardia, audio recording

Brief summary

The aim of this proposal is to characterize the acute effect of early postnatal sound exposure on neuronal maturation of the respiratory control regions of the brain in preterm infants.

Detailed description

The aim of this proposal is to characterize the acute effect of early postnatal sound exposure on neuronal maturation of the respiratory control regions of the brain in preterm infants. We hypothesize that exposure to appropriately designed womb-like sounds in the Neonatal Intensive Care Unit (NICU) will induce a more mature and stabilized cardiorespiratory pattern manifesting as a decrease in apnea, bradycardia, intermittent hypoxemia and mean heart rate. This proposal lays the foundation for further development of actual womb and maternal voice recordings containing components that closely mimic the womb environment during 33-34 weeks of gestation, a proposed therapeutic window of brain development. These sound recordings will provide low risk interventions sorely needed to stabilize respiration, reduce intermittent hypoxemia and induce maturation of neuronal respiratory networks during this critical stage of development.

Interventions

OTHERWomb sound recordings

Womb sounds will be chosen from commercially available (Amazon) womb recordings using a recording that most closely resembles the womb including maternal heart rate, fetal heartbeat, respiratory sounds, bowel popping sounds and frequency spectra as described by Parga, Daland 2018 et al.

Sponsors

Case Western Reserve University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

The order of the sound exposure will be randomized within each subject. The outcomes assessor (quantifying cardiorespiratory events) will be blinded as to the order of the 6 hour randomization blocks within the 24 hour study.

Intervention model description

This is a single site, single visit study. The order of exposure, two 6 hour periods of ambient noise and two 6 hour periods of sound, will be randomized within each subject for a total of 24hrs of sound exposure.

Eligibility

Sex/Gender
ALL
Age
1 Weeks to 5 Weeks
Healthy volunteers
No

Inclusion criteria

* preterm infants 29-33 weeks gestational age at birth * 34 weeks corrected age * off respiratory support \>1.5 lpm

Exclusion criteria

* on respiratory support \>1.5 lpm * congenital anomalies

Design outcomes

Primary

MeasureTime frameDescription
cardiorespiratory eventsDuring the 24 hour period of randomized blocks of womb sound recordings and ambient noiseApnea (\>20 seconds or shorter with intermittent hypoxemia \<85% or bradycardia \<80bpm)
intermittent hypoxemiaDuring the 24 hour period of randomized blocks of womb sound recordings and ambient noisefalls in oxygen saturation \<85%
mean heart rateDuring the 24 hour period of randomized blocks of womb sound recordings and ambient noisemean heart rate
bradycardiaDuring the 24 hour period of randomized blocks of womb sound recordings and ambient noiseheart rate \<80bpm
body motionDuring the 24 hour period of randomized blocks of womb sound recordings and ambient noisenon-cardiac alterations in the oximeter plethysmograph waveform
respiratory pausesDuring the 24 hour period of randomized blocks of womb sound recordings and ambient noiseRespiratory pauses of \>5sec will be documented to increase the chance of capturing small alterations in respiratory stability.

Countries

United States

Contacts

Primary ContactCynthia Bearer, MD
Cynthia.Bearer@UHhospitals.org216 844-3387

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026